Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+8.67%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$19.6B
AUM Growth
+$2.31B
(+13%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
6.45%
Top 10 Holdings %
Top 10 Hldgs %
14.75%
Holding
723
New
183
Increased
150
Reduced
140
Closed
157
Top Buys
| 1 |
Microsoft
MSFT
|
$316M |
| 2 |
Home Depot
HD
|
$241M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$232M |
| 4 |
lululemon athletica
LULU
|
$226M |
| 5 |
Alibaba
BABA
|
$214M |
Top Sells
| 1 |
Zoom
ZM
|
$270M |
| 2 |
Apple
AAPL
|
$263M |
| 3 |
TE Connectivity
TEL
|
$242M |
| 4 |
Meta Platforms (Facebook)
META
|
$211M |
| 5 |
Qualcomm
QCOM
|
$201M |
Sector Composition
| 1 | Technology | 23.88% |
| 2 | Consumer Discretionary | 18.76% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 12.54% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTST
401
NETSTREIT Corp
NTST
$1.72B
| $2.5M | 0.01% |
+151,286
| New | +$2.5M |
|
402
Elutia
ELUT
$79.7M
| $2.45M | 0.01% |
643,445
+551,468
| +600% | +$2.1M |
|
403
Solid Biosciences
SLDB
$428M
| $2.41M | 0.01% |
346,371
-100,000
| -22% | -$697K |
|
|
AMPS
404
DELISTED
Altus Power, Inc.
AMPS
| $2.39M | 0.01% |
750,000
| – | – |
|
405
Core & Main
CNM
$12.7B
| $2.38M | 0.01% |
53,638
-373,043
| -87% | -$16.6M |
|
|
RWT
406
Redwood Trust
RWT
$823M
| $2.36M | 0.01% |
305,460
+105,460
| +53% | +$815K |
|
407
Acumen Pharmaceuticals
ABOS
$87.2M
| $2.33M | 0.01% |
939,603
| – | – |
|
408
Biohaven
BHVN
$1.68B
| $2.32M | 0.01% |
46,351
| – | – |
|
|
NOVA
409
DELISTED
Sunnova Energy
NOVA
| $2.31M | 0.01% |
+237,668
| New | +$2.31M |
|
410
Skechers
SKX
$9.5B
| $2.26M | 0.01% |
33,810
-857,249
| -96% | -$57.4M |
|
411
Achieve Life Sciences
ACHV
$145M
| $2.23M | 0.01% |
471,000
| – | – |
|
412
Alphatec Holdings
ATEC
$2.43B
| $2.22M | 0.01% |
398,846
-931,956
| -70% | -$5.18M |
|
413
Skye Bioscience
SKYE
$124M
| $2.17M | 0.01% |
554,177
+254,177
| +85% | +$994K |
|
414
GCM Grosvenor
GCMG
$680M
| $2.16M | 0.01% |
191,053
| – | – |
|
|
LAC
415
Lithium Americas
LAC
$698M
| $2.16M | 0.01% |
800,000
| – | – |
|
416
PSQ Holdings
PSQH
$73.9M
| $2.1M | 0.01% |
855,009
+150,000
| +21% | +$369K |
|
417
MDxHealth
MDXH
$175M
| $2.09M | 0.01% |
+1,007,000
| New | +$2.09M |
|
418
ASP Isotopes
ASPI
$755M
| $2.08M | 0.01% |
+747,022
| New | +$2.08M |
|
419
CompoSecure
CMPO
$1.89B
| $2.03M | 0.01% |
+174,705
| New | +$2.03M |
|
420
EyePoint Pharmaceuticals
EYPT
$966M
| $2.01M | 0.01% |
251,348
| – | – |
|
|
RNTX
421
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $1.91M | 0.01% |
540,000
| – | – |
|
422
M&T Bank
MTB
$31.2B
| $1.86M | 0.01% |
+10,429
| New | +$1.86M |
|
|
BCAX
423
Bicara Therapeutics Inc. Common Stock
BCAX
$658M
| $1.85M | 0.01% |
+72,807
| New | +$1.85M |
|
424
TORM
TRMD
$2.25B
| $1.82M | 0.01% |
+53,175
| New | +$1.82M |
|
425
ARS Pharmaceuticals
SPRY
$995M
| $1.81M | 0.01% |
+125,000
| New | +$1.81M |
|